• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗在左主干冠状动脉狭窄中与搭桥手术一样有效吗?

Is percutaneous coronary intervention as effective as bypass surgery in left main stem coronary artery stenosis?

作者信息

Stiermaier T, Schuler G, Boudriot E, Desch S, Thiele H

机构信息

Department of Internal Medicine-Cardiology, University of Leipzig Heart Center, Strümpellstrasse 39, Leipzig, Germany.

出版信息

Herz. 2013 Mar;38(2):147-52. doi: 10.1007/s00059-012-3745-3.

DOI:10.1007/s00059-012-3745-3
PMID:23324915
Abstract

Recent advances in percutaneous coronary intervention (PCI) have rekindled interest in this treatment modality also in the setting of unprotected left main stenosis. Randomized trials reported a similar risk of death or myocardial infarction between PCI and coronary artery bypass grafting (CABG). However, rates of stroke were higher after CABG, whereas patients undergoing PCI had a higher risk of repeat revascularization. Although CABG remains the standard of care for left main stenosis in current guideline recommendations, PCI is considered a reasonable alternative in patients with low to intermediate anatomical complexity and at increased surgical risk. An interdisciplinary assessment is indispensable in order to choose the best treatment option for each individual patient.

摘要

经皮冠状动脉介入治疗(PCI)的最新进展重新激发了人们对这种治疗方式在无保护左主干狭窄情况下的兴趣。随机试验报告称,PCI与冠状动脉旁路移植术(CABG)之间的死亡或心肌梗死风险相似。然而,CABG后的卒中发生率较高,而接受PCI的患者再次血运重建的风险较高。尽管在当前指南推荐中,CABG仍然是左主干狭窄的标准治疗方法,但对于解剖复杂性低至中等且手术风险增加的患者,PCI被认为是一种合理的替代方案。为每个患者选择最佳治疗方案,跨学科评估必不可少。

相似文献

1
Is percutaneous coronary intervention as effective as bypass surgery in left main stem coronary artery stenosis?经皮冠状动脉介入治疗在左主干冠状动脉狭窄中与搭桥手术一样有效吗?
Herz. 2013 Mar;38(2):147-52. doi: 10.1007/s00059-012-3745-3.
2
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
3
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.左主干冠状动脉疾病中支架与冠状动脉旁路移植术的 10 年结果比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
4
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
5
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.左主干病变经依维莫司洗脱支架或旁路手术后的生活质量:EXCEL 试验结果。
J Am Coll Cardiol. 2017 Dec 26;70(25):3113-3122. doi: 10.1016/j.jacc.2017.10.036. Epub 2017 Oct 30.
6
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Stenosis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干冠状动脉狭窄。
Am J Med Sci. 2019 Mar;357(3):230-241. doi: 10.1016/j.amjms.2018.12.007. Epub 2018 Dec 21.
7
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.左主干血运重建经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗慢性肾脏病患者: EXCEL 试验。
J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.
8
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
9
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.无保护左主干冠状动脉疾病患者经皮冠状动脉血运重建与冠状动脉旁路移植术的临床结局:6项随机试验和4686例患者的荟萃分析
Am Heart J. 2017 Aug;190:54-63. doi: 10.1016/j.ahj.2017.05.005. Epub 2017 May 18.
10
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较:SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.

本文引用的文献

1
Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.依维莫司洗脱支架植入术治疗无保护左主干冠状动脉狭窄。PRECOMBAT-2(左主干冠状动脉疾病患者中使用依维莫司洗脱支架的旁路手术与血管成形术的随机比较的初步结果)研究。
JACC Cardiovasc Interv. 2012 Jul;5(7):708-17. doi: 10.1016/j.jcin.2012.05.002.
2
Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era.药物洗脱支架时代无保护左主干冠状动脉分叉病变经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期结局。
Heart. 2012 May;98(10):799-805. doi: 10.1136/heartjnl-2011-300753. Epub 2012 Mar 15.
3
Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. A meta-analysis of randomized controlled trials.冠状动脉搭桥手术与经皮冠状动脉介入治疗无保护左主干病变的比较:随机对照试验的荟萃分析
Herz. 2013 Feb;38(1):48-56. doi: 10.1007/s00059-012-3596-y. Epub 2012 Mar 11.
4
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.美国经皮冠状动脉旁路移植术治疗无保护左主干冠状动脉狭窄的特征和长期预后:来自国家心血管数据注册中心的报告,2004 年至 2008 年。
J Am Coll Cardiol. 2012 Feb 14;59(7):648-54. doi: 10.1016/j.jacc.2011.10.883.
5
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南。美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.
6
Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials.经皮冠状动脉介入治疗与旁路手术治疗左主干冠状动脉疾病:随机试验的荟萃分析。
EuroIntervention. 2011 Oct 30;7(6):738-46, 1. doi: 10.4244/EIJV7I6A117.
7
Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉疾病的比较:随机临床数据的荟萃分析。
J Am Coll Cardiol. 2011 Sep 27;58(14):1426-32. doi: 10.1016/j.jacc.2011.07.005.
8
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.比较冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干和/或三血管病变:SYNTAX 试验 3 年随访结果。
Eur Heart J. 2011 Sep;32(17):2125-34. doi: 10.1093/eurheartj/ehr213. Epub 2011 Jun 22.
9
Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.无保护左主干病变经药物洗脱支架或冠状动脉旁路移植术治疗患者的动脉粥样硬化性冠状动脉疾病的复杂性及长期结局。
J Am Coll Cardiol. 2011 May 24;57(21):2152-9. doi: 10.1016/j.jacc.2011.01.033.
10
Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.无保护左主干冠状动脉分叉病变中,西罗莫司洗脱支架与紫杉醇洗脱支架的长期疗效对比。
Clin Cardiol. 2011 Jun;34(6):378-83. doi: 10.1002/clc.20887. Epub 2011 Apr 27.